SCHEMBL21036085

SCHEMBL21036085

CC(=O)N[C@@H](CC(C)(C)C)C(=O)N1CCNCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.37
CHRM5 P08912 1/20 0.36
CHRM3 P20309 1/20 0.36
HPGD P15428 1/20 0.36
ALDH1A1 P00352 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
F2 P00734 2/20 0.35
KMT2A Q03164 1/20 0.34
CA2 P00918 2/20 0.33
PKM P14618 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA9 Q16790 1/20 0.33
UGCG Q16739 1/20 0.33
ITGB3 P05106 1/20 0.33
ITGA2B P08514 1/20 0.33
PADI1 Q9ULC6 1/20 0.33
PADI4 Q9UM07 1/20 0.33
TPSAB1 Q15661 1/20 0.33
TPSD1 Q9BZJ3 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23868501 0.86 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2KMT2AITGB3ITGA2B
SCHEMBL21035835 0.85 CHEK1 (0.39) SIGMAR1CHRM5CHRM3HPGDF2
SCHEMBL20994235 0.85 CYP3A4 (0.40) ALDH1A1SMN1; SMN2UGCGITGB3ITGA2B
SCHEMBL20994238 0.85 CYP3A4 (0.40) ALDH1A1SMN1; SMN2UGCGITGB3ITGA2B
SCHEMBL16748082 0.84 SIGMAR1 (0.39) SIGMAR1CHRM5CHRM3HPGDF2
SCHEMBL7713758 0.83 SMN1; SMN2 (0.50) CHRM5CHRM3ALDH1A1SMN1; SMN2F2
SCHEMBL17011282 0.82 SIGMAR1 (0.37) SIGMAR1CHRM5CHRM3HPGDF2
SCHEMBL23394687 0.79 CHRM5 (0.36) CHRM5CHRM3ALDH1A1SMN1; SMN2F2
SCHEMBL21124325 0.78 PLD1 (0.36) SIGMAR1F2
SCHEMBL21036475 0.78 PLD1 (0.36) SIGMAR1F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3489231-B1 PIPERAZINE DERIVATIVE ASTELLAS PHARMA INC (JP) 2021-06-09 EP disclosed
EP-3489231-A1 PIPERAZINE DERIVATIVE Astellas Pharma Inc. (JP) 2019-05-29 EP disclosed